Jim Cramer's hopeful on Abbott Labs after court case win

Published on 2 Nov 2024 on CNBC

CNBC's Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that's...

Read the rest of the article

Start tracking your investments with Statfolio

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. ...

Insider Monkey · via Yahoo Finance 7 Nov 2024

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we ar...

Insider Monkey · via Yahoo Finance 5 Nov 2024

CNBC's Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that...

CNBC 2 Nov 2024

The verdict dismissed claims that the companies had failed to adequately warn of risks associated...

Investing.com 1 Nov 2024

Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London...

Investopedia · via Yahoo Finance 1 Nov 2024

Abbott Laboratories shares jumped Friday after the Club holding picked up a surprise victory in a...

CNBC 1 Nov 2024

A jury in St. Louis, Missouri found on Thursday that Abbott and Reckitt unit Mead Johnson are not...

Reuters · via Yahoo Finance 1 Nov 2024

Abbott Laboratories is the #1 healthcare stock to own over the long term, providing a market-beat...

Investing.com 31 Oct 2024

Instead of using future free cash flow as in the traditional DCF model, the GuruFocus DCF calcula...

GuruFocus.com · via Yahoo Finance 30 Oct 2024

David Jagielski (Abbott Laboratories): When you're looking for good dividend growth stocks to hol...

The Motley Fool 26 Oct 2024